IDRA

Idera Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

CEO

Vincent J. Milano

IPO Date

1996-01-25

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

News SentimentBearish

Articles

Avg Positive

13.1%

Avg Negative

29.6%

Avg Neutral

57.3%

News Feed

IDRA Stock Price Increases Over 20% Pre-Market: Why It Happened

Idera Pharmaceuticals Announces Corporate Updates

Idera Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update